Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Amortization of Deferred Charges (2023)

60 Degrees Pharmaceuticals (SXTP) has disclosed Amortization of Deferred Charges for 2 consecutive years, with $125368.0 as the latest value for Q1 2024.

  • On a quarterly basis, Amortization of Deferred Charges rose 419.23% to $125368.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $173793.0, a N/A change, with the full-year FY2023 number at $669148.0, down 38.63% from a year prior.
  • Amortization of Deferred Charges was $125368.0 for Q1 2024 at 60 Degrees Pharmaceuticals, up from $23812.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $125368.0 in Q1 2024 to a low of $23812.0 in Q3 2023.